Annals of African Medicine
Home About AAM Editorial board Ahead of print Current Issue Archives Instructions Subscribe Contact us Search Login 

    Article Cited by others

REVIEW ARTICLE

Current management of Parkinson's disease

Salawu F, Olokoba A, Danburam A

Year : 2010| Volume: 9| Issue : 2 | Page no: 55-61

   This article has been cited by
 
1 GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease
D.B. Hoban,L. Howard,E. Dowd
Neuroscience. 2015; 303: 402
[Pubmed]  [Google Scholar] [DOI]
2 Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinsonæs disease models
Q. Wang,L. Qian,S.-H. Chen,C.-H. Chu,B. Wilson,E. Oyarzabal,S. Ali,B. Robinson,D. Rao,J.-S. Hong
Brain. 2015;
[Pubmed]  [Google Scholar] [DOI]
3 A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function
Littrell, O.M. and Fuqua, J.L. and Richardson, A.D. and Turchan-Cholewo, J. and Hascup, E.R. and Huettl, P. and Pomerleau, F. and Bradley, L.H. and Gash, D.M. and Gerhardt, G.A.
Neuropeptides. 2013; 47(1): 43-49
[Pubmed]  [Google Scholar]
4 Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: Application of factorial design approach
Pardeshi, C.V. and Rajput, P.V. and Belgamwar, V.S. and Tekade, A.R. and Surana, S.J.
Drug Delivery. 2013; 20(1): 47-56
[Pubmed]  [Google Scholar]
5 The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinsonæs disease
Li Zuo,Michael S. Motherwell
Gene. 2013; 532(1): 18
[Pubmed]  [Google Scholar] [DOI]
6 Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach
Chandrakantsing V. Pardeshi,Pravin V. Rajput,Veena S. Belgamwar,Avinash R. Tekade,Sanjay J. Surana
Drug Delivery. 2013; 20(1): 47
[Pubmed]  [Google Scholar] [DOI]
7 Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation
Chandrakantsing V. Pardeshi,Veena S. Belgamwar,Avinash R. Tekade,Sanjay J. Surana
Journal of Materials Science: Materials in Medicine. 2013; 24(9): 2101
[Pubmed]  [Google Scholar] [DOI]
8 A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function
O.M. Littrell,J.L. Fuqua,A.D. Richardson,J. Turchan-Cholewo,E.R. Hascup,P. Huettl,F. Pomerleau,L.H. Bradley,D.M. Gash,G.A. Gerhardt
Neuropeptides. 2013; 47(1): 43
[Pubmed]  [Google Scholar] [DOI]
9 Mifepristone-inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivo
Wang, Y., Yang, D., Song, L., Li, T., Yang, J., Zhang, X., Le, W.
Stem Cells. 2012; 30(2): 169-179
[Pubmed]  [Google Scholar]
10 Mifepristone-Inducible Caspase-1 Expression in Mouse Embryonic Stem Cells Eliminates Tumor Formation but Spares Differentiated Cells In Vitro and In Vivo
Yi Wang,Dehua Yang,Lin Song,Ting Li,Juan Yang,Xiaojie Zhang,Weidong Le
STEM CELLS. 2012; 30(2): 169
[Pubmed]  [Google Scholar] [DOI]
11 Therapeutic applications of antibodies in non-infectious neurodegenerative diseases
Pavan K. Krishnamurthy,Einar M. Sigurdsson
New Biotechnology. 2011; 28(5): 511
[Pubmed]  [Google Scholar] [DOI]
12 Mitochondrial therapeutics in Alzheimeræs disease and Parkinsonæs disease
Hoekstra, J.G. and Montine, K.S. and Zhang, J. and Montine, T.J.
Alzheimeræs Research and Therapy. 2011; 3(3)
[Pubmed]  [Google Scholar]
13 Therapeutic applications of antibodies in non-infectious neurodegenerative diseases
Krishnamurthy, P.K., Sigurdsson, E.M.
New Biotechnology. 2011; 28(5): 511-517
[Pubmed]  [Google Scholar]

 

Read this article